Correspondence
Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study. Reply from authors
D. Rigopoulos,
D. Rigopoulos
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author S. Gregoriou,
S. Gregoriou
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author H. Belyayeva,
H. Belyayeva
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author G. Larios,
G. Larios
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author G. Kontochristopoulos,
G. Kontochristopoulos
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author A. Katsambas,
A. Katsambas
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author
D. Rigopoulos,
D. Rigopoulos
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author S. Gregoriou,
S. Gregoriou
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author H. Belyayeva,
H. Belyayeva
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author G. Larios,
G. Larios
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author G. Kontochristopoulos,
G. Kontochristopoulos
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author A. Katsambas,
A. Katsambas
Department of Dermatology, Andreas Sygros Hospital, University of Athens, Athens, Greece
Search for more papers by this author
First published: 24 June 2010
S. Gregoriou.E-mail: [email protected]
No abstract is available for this article.
References
- 1
Rao A,
Bunker C.
Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study.
Br J Dermatol
2010; 163:206.
- 2
Tosti A,
Piraccini BM,
Ghetti E,
Colombo MD.
Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study.
J Am Acad Dermatol
2002; 47: 73–6.
- 3
Rigopoulos D,
Gregoriou S,
Belyayeva E
et al.
Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study.
Br J Dermatol
2009; 160: 858–60.
